DEUTERATED ELAGOLIX DERIVATIVE, PHARMACEUTICAL COMPOSITION, AND USES THEREOF

Title:

DEUTERATED ELAGOLIX DERIVATIVE, PHARMACEUTICAL COMPOSITION, AND USES THEREOF

Document Type and Number:

WIPO Patent Application WO/2019/129310

Kind Code:

A1

Abstract:

Disclosed are a deuterated elagolix derivative, a pharmaceutical composition, and uses thereof. The structure of the deuterated elagolix derivative of the present invention is as shown in formula (X). The deuterated elagolix derivative as shown in formula (X) of the present invention functions as a GnRH receptor antagonist, and can treat and/or prevent sex hormone-related diseases. Also disclosed is a pharmaceutical composition containing the deuterated elagolix derivative and a pharmaceutically acceptable vector, and a method for using said pharmaceutical composition to antagonize the in-vivo release of gonadotropin.

More Like This:

JPS603071	[Title of the Invention] A manufacturing method of 1-(alpha-acyloxy Alkyl)-5-fluorouracils
JP2021510382	Substituted thiophenyluracil, its salt and its use as a herbicide

Inventors:

ZHU XIAOYUN (CN)
JIANG WEIPING (CN)

Application Number:

PCT/CN2019/076396

Publication Date:

July 04, 2019

Filing Date:

February 28, 2019

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ANDIKANG WUXI BIOLOGICAL TECH CO LTD (CN)

International Classes:

C07D239/54; A61K31/513; A61P1/00; A61P13/08; A61P15/08; A61P17/06; A61P19/00; A61P25/20; A61P35/00; A61P37/02; C07B59/00

Foreign References:

CN1819829A	2006-08-16
CN108129400A	2018-06-08

Attorney, Agent or Firm:

SHANGHAI BESHINING LAW OFFICE (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: PREPARATION METHOD FOR DEXAMETHASONE INTERMEDIATE

Next Patent: CONTROL METHOD, APPARATUS, DEVICE, AND MEDIUM FOR POWER FACTOR CORRECTION PFC CIRCUIT